tiprankstipranks
Hookipa Pharma doses first patient in HB-500 trial
PremiumThe FlyHookipa Pharma doses first patient in HB-500 trial
19d ago
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
PremiumPress Releases
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
19d ago
Hookipa Pharma price target raised to $6 from $5 at H.C. Wainwright
PremiumThe Fly
Hookipa Pharma price target raised to $6 from $5 at H.C. Wainwright
2M ago
Hookipa Pharma to host conference call
PremiumThe FlyHookipa Pharma to host conference call
2M ago
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
PremiumPress Releases
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
2M ago
Hookipa Pharma announces updated HB-200 trial results
PremiumThe Fly
Hookipa Pharma announces updated HB-200 trial results
2M ago
Hookipa Pharma Announces Major HB-200 Clinical Trial Design
PremiumCompany AnnouncementsHookipa Pharma Announces Major HB-200 Clinical Trial Design
3M ago
Hookipa Pharma announces Phase 2/3 trial design for HB-200
PremiumThe Fly
Hookipa Pharma announces Phase 2/3 trial design for HB-200
3M ago
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
PremiumPress Releases
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100